UroGen Pharma(URGN) - 2021 Q4 - Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2021 Earnings Conference Call March 21, 2022 10:00 AM ET Company Participants Vincent Perrone - Senior Director of Investor Relations Liz Barrett - President and Chief Executive Officer Mark Schoenberg - Chief Medical Officer Jeff Bova - Chief Commercial Officer Molly Henderson - Chief Financial Officer Conference Call Participants Boris Peaker - Cowen Christopher Howerton - Jefferies Ram Selvaraju - H.C. Wainwright Matt Kaplan - Ladenburg Thalmann Operator Good morning, ...